COVID-19 sequelae in adults aged less than 50 years: A systematic review

Sandra Willi(University of Zurich), Patricia Schlagenhauf(World Health Organization - Pakistan), Renata Vidonscky Lüthold(University of Bern), Camila Scaff(University of Zurich), Donikë Sejdiu(University of Zurich), Kaspar Staub(University of Bern), Nadescha Viviane Hänggi(University of Zurich), Adam Hunt(University of Zurich), Nicole Bender(University of Zurich)
Travel Medicine and Infectious Disease
February 22, 2021
10.1016/j.tmaid.2021.101995
Cited by 188

Related Papers

Covid-19 and community mitigation strategies in a pandemic
|BMJ|2020|584
Going global – Travel and the 2019 novel coronavirus
|Travel Medicine and Infectious Disease|2020|376
Chikungunya and dengue autochthonous cases in Europe, 2007–2012
|Travel Medicine and Infectious Disease|2013|255
Travel-associated infection presenting in Europe (2008–12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation
|The Lancet Infectious Diseases|2014|248
Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study
|BMJ|2003|243